BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26095193)

  • 41. Double-stranded RNA adenosine deaminases ADAR1 and ADAR2 have overlapping specificities.
    Lehmann KA; Bass BL
    Biochemistry; 2000 Oct; 39(42):12875-84. PubMed ID: 11041852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenosine-to-Inosine RNA Editing Enzyme ADAR and microRNAs.
    Yuting K; Ding D; Iizasa H
    Methods Mol Biol; 2021; 2181():83-95. PubMed ID: 32729076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. RNA sequences that direct selective ADAR editing from a SELEX library bearing 8-azanebularine.
    Wong BL; Mendoza HG; Jacobsen CS; Beal PA
    Bioorg Med Chem; 2024 Apr; 104():117700. PubMed ID: 38583236
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative Activity of Adenosine Deaminase Acting on RNA (ADARs) Isoforms for Correction of Genetic Code in Gene Therapy.
    Azad MTA; Qulsum U; Tsukahara T
    Curr Gene Ther; 2019; 19(1):31-39. PubMed ID: 30426900
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
    Ganem NS; Ben-Asher N; Lamm AT
    Drug Resist Updat; 2017 May; 32():16-22. PubMed ID: 29145975
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Specificity of ADAR-mediated RNA editing in newly identified targets.
    Riedmann EM; Schopoff S; Hartner JC; Jantsch MF
    RNA; 2008 Jun; 14(6):1110-8. PubMed ID: 18430892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Structure and sequence determinants required for the RNA editing of ADAR2 substrates.
    Dawson TR; Sansam CL; Emeson RB
    J Biol Chem; 2004 Feb; 279(6):4941-51. PubMed ID: 14660658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
    Hong H; An O; Chan THM; Ng VHE; Kwok HS; Lin JS; Qi L; Han J; Tay DJT; Tang SJ; Yang H; Song Y; Bellido Molias F; Tenen DG; Chen L
    Nucleic Acids Res; 2018 Sep; 46(15):7953-7969. PubMed ID: 29796672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro and in cellula site-directed RNA editing using the λNDD-BoxB system.
    Ojha N; Diaz Quiroz JF; Rosenthal JJC
    Methods Enzymol; 2021; 658():335-358. PubMed ID: 34517953
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations.
    Hajji K; Sedmík J; Cherian A; Amoruso D; Keegan LP; O'Connell MA
    RNA; 2022 Oct; 28(10):1281-1297. PubMed ID: 35863867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA-editing enzymes ADAR1 and ADAR2 coordinately regulate the editing and expression of Ctn RNA.
    Anantharaman A; Gholamalamdari O; Khan A; Yoon JH; Jantsch MF; Hartner JC; Gorospe M; Prasanth SG; Prasanth KV
    FEBS Lett; 2017 Sep; 591(18):2890-2904. PubMed ID: 28833069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
    Mannion N; Arieti F; Gallo A; Keegan LP; O'Connell MA
    Biomolecules; 2015 Sep; 5(4):2338-62. PubMed ID: 26437436
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zinc Finger RNA-Binding Protein Zn72D Regulates ADAR-Mediated RNA Editing in Neurons.
    Sapiro AL; Freund EC; Restrepo L; Qiao HH; Bhate A; Li Q; Ni JQ; Mosca TJ; Li JB
    Cell Rep; 2020 May; 31(7):107654. PubMed ID: 32433963
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The RNA editing enzymes ADARs: mechanism of action and human disease.
    Tomaselli S; Locatelli F; Gallo A
    Cell Tissue Res; 2014 Jun; 356(3):527-32. PubMed ID: 24770896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A-to-I RNA editing - thinking beyond the single nucleotide.
    Ganem NS; Lamm AT
    RNA Biol; 2017 Dec; 14(12):1690-1694. PubMed ID: 28820319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanistic insights into editing-site specificity of ADARs.
    Kuttan A; Bass BL
    Proc Natl Acad Sci U S A; 2012 Nov; 109(48):E3295-304. PubMed ID: 23129636
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adenosine deaminases acting on RNA (ADARs) are both antiviral and proviral.
    Samuel CE
    Virology; 2011 Mar; 411(2):180-93. PubMed ID: 21211811
    [TBL] [Abstract][Full Text] [Related]  

  • 58. RNA Editing by ADAR Adenosine Deaminases: From Molecular Plasticity of Neural Proteins to the Mechanisms of Human Cancer.
    Goncharov AO; Kliuchnikova AA; Nasaev SS; Moshkovskii SA
    Biochemistry (Mosc); 2019 Aug; 84(8):896-904. PubMed ID: 31522671
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective inhibition of ADAR2-catalyzed editing of the serotonin 2c receptor pre-mRNA by a helix-threading peptide.
    Schirle NT; Goodman RA; Krishnamurthy M; Beal PA
    Org Biomol Chem; 2010 Nov; 8(21):4898-904. PubMed ID: 20820662
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genome-wide quantification of ADAR adenosine-to-inosine RNA editing activity.
    Roth SH; Levanon EY; Eisenberg E
    Nat Methods; 2019 Nov; 16(11):1131-1138. PubMed ID: 31636457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.